Greiner Bio-One North America, Inc. has acquired 3D Cell Culture Technology previously owned by Nano 3D Biosciences, Inc. As an international distributor of these products since 2016, Greiner Bio-One has now taken the initiative to become a premier provider of this technology worldwide.
Magnetic 3D cell culture has become a disruptive technology in the research marketplace by offering an improved method for growing cells and driving results in new pathways to disease treatment and prevention.
Heinz Schmid, CEO of Greiner Bio-One BioScience commented on this strategic acquisition: “The potential for growth in the 3D cell culture market is amazingly vast with laboratories and research facilities utilising this new technology daily to find cures for disease and improve the existing cell culture methodology. The acquisition of a magnetic 3D cell culture technology is just one of Greiner Bio-One’s ongoing efforts to advance scientific research and improve health, while providing researchers access to the best products.”
Nano3D Biosciences, Inc. President and Chief Scientific Officer, Glauco Souza: "We are delighted to have completed this acquisition with Greiner Bio-One. The synergy between Nano3D's technology and Greiner Bio-One’s innovation in tissue culture makes this an excellent match to further advance magnetic 3D cell culture."